109 related articles for article (PubMed ID: 8872915)
21. Neutrophil aggregation--factors modulating stimulus-specific responses.
Ringertz B
Acta Pathol Microbiol Immunol Scand C; 1986 Feb; 94(1):1-9. PubMed ID: 3012935
[TBL] [Abstract][Full Text] [Related]
22. Dynamics of human neutrophil aggregation evaluated by flow cytometry.
Rochon YP; Frojmovic MM
J Leukoc Biol; 1991 Nov; 50(5):434-43. PubMed ID: 1748839
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of neutrophil activation by nonsteroidal anti-inflammatory drugs.
Abramson S; Edelson H; Kaplan H; Ludewig R; Weissmann G
Am J Med; 1984 Oct; 77(4B):3-6. PubMed ID: 6093509
[TBL] [Abstract][Full Text] [Related]
24. Human neutrophil Fc gamma RIIIB and formyl peptide receptors are functionally linked during formyl-methionyl-leucyl-phenylalanine-induced chemotaxis.
Kew RR; Grimaldi CM; Furie MB; Fleit HB
J Immunol; 1992 Aug; 149(3):989-97. PubMed ID: 1321856
[TBL] [Abstract][Full Text] [Related]
25. The prostaglandin paradox: additive inhibition of neutrophil function by aspirin-like drugs and the prostaglandin E1 analog misoprostol.
Kitsis EA; Weissmann G; Abramson SB
J Rheumatol; 1991 Oct; 18(10):1461-5. PubMed ID: 1662723
[TBL] [Abstract][Full Text] [Related]
26. Sulfasalazine inhibition of binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human neutrophils.
Stenson WF; Mehta J; Spilberg I
Biochem Pharmacol; 1984 Feb; 33(3):407-12. PubMed ID: 6142713
[TBL] [Abstract][Full Text] [Related]
27. The down-regulation of FcgammaRII and FcgammaRIIIB by N-formyl-methionyl-leucyl-phenylalanine (FMLP) depends on secretory events in human neutrophils.
Alves-Rosa MF; Vulcano M; Beigier M; Breyer I; Isturiz MA
Immunol Lett; 1999 Nov; 70(2):119-26. PubMed ID: 10569701
[TBL] [Abstract][Full Text] [Related]
28. Role of arachidonic acid derivatives in neutrophil aggregation: a hypothesis.
O'Flaherty JT; Showell HJ; Becker EL; Ward PA
Prostaglandins; 1979 Jun; 17(6):915-27. PubMed ID: 504694
[TBL] [Abstract][Full Text] [Related]
29. Nonsteroidal anti-inflammatory drug as tools for analysis of neutrophil functions.
Périanin A; Giroud JP; Hakim J
Biomed Pharmacother; 1987; 41(6):315-21. PubMed ID: 3446289
[TBL] [Abstract][Full Text] [Related]
30. Effect of indomethacin and aspirin on the TNF-alpha-induced priming and protein tyrosyl phosphorylation of human neutrophils.
Minakami K; Watanabe Y; Miyahara M; Kobuchi H; Kurashige T; Utsumi K
Physiol Chem Phys Med NMR; 1993; 25(1):55-67. PubMed ID: 7686297
[TBL] [Abstract][Full Text] [Related]
31. Specific inhibition of leukotriene B4-induced neutrophil activation by LY223982.
Jackson WT; Boyd RJ; Froelich LL; Mallett BE; Gapinski DM
J Pharmacol Exp Ther; 1992 Dec; 263(3):1009-14. PubMed ID: 1335049
[TBL] [Abstract][Full Text] [Related]
32. Differential inhibition of neutrophil superoxide generation by nonsteroidal antiinflammatory drugs.
Gay JC; Lukens JN; English DK
Inflammation; 1984 Jun; 8(2):209-22. PubMed ID: 6086524
[TBL] [Abstract][Full Text] [Related]
33. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
Liao CH; Cheng JT; Teng CM
Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological modulation of the effects of N-formyl-L-methionyl-L-leucyl-L-phenylalanine in guinea-pigs: involvement of the arachidonic acid cascade.
Boukili MA; Bureau M; Lagente V; Lefort J; Lellouch-Tubiana A; Malanchère E; Vargaftig BB
Br J Pharmacol; 1986 Oct; 89(2):349-59. PubMed ID: 3096407
[TBL] [Abstract][Full Text] [Related]
35. Phospholipase D-dependent and -independent p38MAPK activation pathways are required for superoxide production and chemotactic induction, respectively, in rat neutrophils stimulated by fMLP.
Azuma Y; Kosaka K; Kashimata M
Eur J Pharmacol; 2007 Jul; 568(1-3):260-8. PubMed ID: 17560994
[TBL] [Abstract][Full Text] [Related]
36. Rebamipide suppresses formyl-methionyl-leucyl-phenylalanine (fMLP)-induced superoxide production by inhibiting fMLP-receptor binding in human neutrophils.
Nagano C; Azuma A; Ishiyama H; Sekiguchi K; Imagawa K; Kikuchi M
J Pharmacol Exp Ther; 2001 Apr; 297(1):388-94. PubMed ID: 11259567
[TBL] [Abstract][Full Text] [Related]
37. Agonist-induced calcium flux, phosphoinositide metabolism, aggregation and enzyme secretion in human neutrophils.
Rossi AG; McMillan RM; MacIntyre DE
Agents Actions; 1988 Jul; 24(3-4):272-82. PubMed ID: 2845744
[TBL] [Abstract][Full Text] [Related]
38. Scanning electron microscopic studies on the route of neutrophil extravasation in the mouse after exposure to the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (fMLP).
Hoshi O; Ushiki T
Arch Histol Cytol; 1999 Aug; 62(3):253-60. PubMed ID: 10495880
[TBL] [Abstract][Full Text] [Related]
39. The inhibitory effect of prostaglandin E2 on rat neutrophil aggregation.
Wise H
J Leukoc Biol; 1996 Oct; 60(4):480-6. PubMed ID: 8864132
[TBL] [Abstract][Full Text] [Related]
40. Further investigation into the ocular effects of prostaglandin E2, leukotriene B4 and formyl-methionyl-leucyl phenylalanine.
Bhattacherjee P; Paterson CA
Exp Eye Res; 1990 Jul; 51(1):93-6. PubMed ID: 2164949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
